European Journal of Heart Failure: Vol 19, No 3

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

European Journal of Heart Failure

Journal list menu

Tools

Follow journal

European Journal of Heart Failure: Volume 19, Issue 3

Download PDFs

ISSUE INFORMATION

Issue Information

INTRODUCTION

March 2017 at a glance: pathophysiology, imaging, biomarkers and devices

VIEWPOINTS

The practice gap in heart failure—the elephant in the room

Telemedicine in heart failure: new insights from the Cochrane meta-analyses

REVIEW

Myocardial strain to detect subtle left ventricular systolic dysfunction

PATHOPHYSIOLOGY

Research article

A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study

Editorial comment

Genetic variation expressed in the brain may impact heart failure

Research article

Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes

Editorial comment

Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention

BIOMARKERS

Research articles

Ferritin levels and risk of heart failure—the Atherosclerosis Risk in Communities Study

Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community

Variability of biomarkers in patients with chronic heart failure and healthy controls

DEVICES

Research articles

New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy

The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers

Editorial comment

Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co-morbidities

NOVEL THERAPIES

Research article

Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study

Editorial comment

Neuromodulation for systolic heart failure: more than a placebo effect?

Research article

Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock

Editorial comment

Are two crutches better than one? The ongoing dilemma on the effects and need for left ventricular unloading during veno-arterial extracorporeal membrane oxygenation

TELEMEDICINE

Research articles

Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial

Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials

LETTERS TO THE EDITOR

The real-world evidence of heart failure co-morbidities

Guided left ventricular lead placement for cardiac resynchronization therapy: an opportunity for image integration

Reply

BOOK REVIEW

Emergency Cardiology: A Practical Guide: By Loukianos Rallidis Nicosia, Cyprus: Broken Hill Publishers Ltd, 2017

ERRATA

Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology

This article corrects the following:

Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

This article corrects the following:

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology

This article corrects the following:

Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology

Sign up for email alerts

Tools

More from this journal

Concomitant implantation of Impella^® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock